Skip to content

Study on the effect of Pringle method and hemihepatic vascular occlusion method on clinical indicators of patients undergoing liver tumor resection

A comparative study of hepatectomy with hemi-hepatic blood flow occlusion and hepatic blood flow occlusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045284
Enrollment
Unknown
Registered
2021-04-10
Start date
2019-06-01
Completion date
Unknown
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor

Interventions

Blocked blood flow into the liver group:Use the Pringle method to block the blood vessels entering the liver
Hemihepatic blood flow occlusion group:Block the blood flow of the half liver into the hepatic vessel

Sponsors

Affiliated Hospital of Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
24 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. After admission, he was diagnosed as liver tumor by imaging and clinical diagnosis, including PLC, liver metastasis and liver benign tumor; 2. The patient's liver tumor was in one half of the liver, which meets the indications for surgery and requires surgical treatment; 3. The patient No serious underlying diseases of the heart, lungs and other organs, and can tolerate surgery; 4. The Child classification of liver function before surgery is A or B is changed to A after strict conservative treatment; 5. Obtain the patient's informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with ascites or cachexia; 2. There are both hemilivers on the left and right sides of the tumor; 3. There are distant metastases or infiltration of surrounding tissues and blood vessels in patients with liver cancer; 4. Pregnant or lactating women; 5. With basic coagulation dysfunction; 6. Postoperative pathological reports of non-liver tumors; 7. Patients who have undergone interventional liver tumor embolization or chemotherapy; 8. Patients who have undergone upper abdominal surgery; 9. Tumor invades the common bile duct or primary common bile duct disease, and patients undergoing intraoperative cholangiojejunostomy.

Design outcomes

Primary

MeasureTime frame
Blocking time;operation time;Bleeding volume;Bleeding volume per unit area;Blood transfusion;Postoperative complications;Hospital stay;Hospital costs;Liver function;

Secondary

MeasureTime frame
Hemihepatectomy;Maximum tumor diameter;Histopathological type;

Countries

China

Contacts

Public ContactDong Qin

Affiliated Hospital of Inner Mongolia Medical University

nmhhdq@163.com+86 13848121445

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026